Background There have been no studies of the patterns of post-marketing withdrawals of
medicinal products to which adverse reactions have been attributed. We identified medicinal …

Adverse drug reactions (ADRs) remain a challenge in modern healthcare, particularly given
the increasing complexity of therapeutics, an ageing population and rising multimorbidity …

Objective Social media is becoming increasingly popular as a platform for sharing personal
health-related information. This information can be utilized for public health monitoring tasks …

Public Health England exists to protect and improve the nation's health and wellbeing, and
reduce health inequalities. We do this through world-leading science, research, knowledge …

Aims Current trends in pharmacovigilance systems are veering towards patient involvement
in spontaneous reporting of adverse drug reactions (ADRs). The aim of the current …

Drug use in medicine is based on a balance between expected benefits (already
investigated before marketing authorization) and possible risks (ie, adverse effects), which …

In the past 20 years, many low-and middle-income countries have created national
pharmacovigilance (PV) systems and joined the WHO's global PV network. However, very …

Objective: Identifying the main causes for underreporting of Adverse Drug Reaction (ADR)
by health professionals. Method: A systematic review carried out in the following databases …

Aim The aim of the present study was to determine the barriers and motives influencing
consumer reporting of adverse drug reactions (ADRs). Methods A systematic review, guided …

Background Spontaneous reporting is the most used method to monitor post-marketing
safety information. Although patient involvement in spontaneous reporting has increased …